These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 29388284)
1. Pain-relieving effectiveness, quality of life and tolerability of repeated capsaicin 8% patch treatment of peripheral neuropathic pain in Scandinavian clinical practice. Hansson P; Jensen TS; Kvarstein G; Strömberg M Eur J Pain; 2018 May; 22(5):941-950. PubMed ID: 29388284 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study. Mankowski C; Poole CD; Ernault E; Thomas R; Berni E; Currie CJ; Treadwell C; Calvo JI; Plastira C; Zafeiropoulou E; Odeyemi I BMC Neurol; 2017 Apr; 17(1):80. PubMed ID: 28431564 [TBL] [Abstract][Full Text] [Related]
3. Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study. Maihofner C; Heskamp ML Curr Med Res Opin; 2013 Jun; 29(6):673-83. PubMed ID: 23551064 [TBL] [Abstract][Full Text] [Related]
4. 8% Capsaicin Patch in Treatment of Peripheral Neuropathic Pain. Goncalves D; Rebelo V; Barbosa P; Gomes A Pain Physician; 2020 Sep; 23(5):E541-E548. PubMed ID: 32967405 [TBL] [Abstract][Full Text] [Related]
5. Patients' Global Impression of Change in the management of peripheral neuropathic pain: Clinical relevance and correlations in daily practice. Perrot S; Lantéri-Minet M Eur J Pain; 2019 Jul; 23(6):1117-1128. PubMed ID: 30793414 [TBL] [Abstract][Full Text] [Related]
6. The capsaicin 8% patch for neuropathic pain in clinical practice: a retrospective analysis. Wagner T; Poole C; Roth-Daniek A Pain Med; 2013 Aug; 14(8):1202-11. PubMed ID: 23710678 [TBL] [Abstract][Full Text] [Related]
7. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Derry S; Sven-Rice A; Cole P; Tan T; Moore RA Cochrane Database Syst Rev; 2013 Feb; (2):CD007393. PubMed ID: 23450576 [TBL] [Abstract][Full Text] [Related]
8. Capsaicin 8% patch versus oral pregabalin in patients with peripheral neuropathic pain. Haanpää M; Cruccu G; Nurmikko TJ; McBride WT; Docu Axelarad A; Bosilkov A; Chambers C; Ernault E; Abdulahad AK Eur J Pain; 2016 Feb; 20(2):316-28. PubMed ID: 26581442 [TBL] [Abstract][Full Text] [Related]
9. Capsaicin 8% Dermal Patch: A Review in Peripheral Neuropathic Pain. Blair HA Drugs; 2018 Sep; 78(14):1489-1500. PubMed ID: 30251173 [TBL] [Abstract][Full Text] [Related]
10. Treatment of neuropathic pain with the capsaicin 8% patch: is pretreatment with lidocaine necessary? Kern KU; Nowack W; Poole C Pain Pract; 2014 Feb; 14(2):E42-50. PubMed ID: 24289500 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness and Impact of Capsaicin 8% Patch on Quality of Life in Patients with Lumbosacral Pain: An Open-label Study. Zis P; Bernali N; Argira E; Siafaka I; Vadalouka A Pain Physician; 2016; 19(7):E1049-53. PubMed ID: 27676676 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of 0.625% and 1.25% Capsaicin Patch in Peripheral Neuropathic Pain: Multi-Center, Randomized, and Semi-Double Blind Controlled Study. Moon JY; Lee PB; Kim YC; Lee SC; Nahm FS; Choi E Pain Physician; 2017 Feb; 20(2):27-35. PubMed ID: 28158151 [TBL] [Abstract][Full Text] [Related]
13. QAPSA: post-marketing surveillance of capsaicin 8% patch for long-term use in patients with peripheral neuropathic pain in France. Lantéri-Minet M; Perrot S Curr Med Res Opin; 2019 Mar; 35(3):417-426. PubMed ID: 30550354 [TBL] [Abstract][Full Text] [Related]
14. Superiority of capsaicin 8% patch versus oral pregabalin on dynamic mechanical allodynia in patients with peripheral neuropathic pain. Cruccu G; Nurmikko TJ; Ernault E; Riaz FK; McBride WT; Haanpää M Eur J Pain; 2018 Apr; 22(4):700-706. PubMed ID: 29194851 [TBL] [Abstract][Full Text] [Related]
15. Assessment of the feasibility of high-concentration capsaicin patches in the pain unit of a tertiary hospital for a population of mixed refractory peripheral neuropathic pain syndromes in non-diabetic patients. Giménez-Milà M; Videla S; Navarro MA; Faulí A; Ojeda A; Bogdanovich A; Moreno LA; Hernández-Cera C; Busquets C BMC Anesthesiol; 2014; 14():120. PubMed ID: 25580085 [TBL] [Abstract][Full Text] [Related]
16. Treatment of painful radiculopathies with capsaicin 8% cutaneous patch. Baron R; Treede RD; Birklein F; Cegla T; Freynhagen R; Heskamp ML; Kern KU; Maier C; Rolke R; Seddigh S; Sommer C; Ständer S; Maihöfner C Curr Med Res Opin; 2017 Aug; 33(8):1401-1411. PubMed ID: 28436279 [TBL] [Abstract][Full Text] [Related]
17. NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: results of a 52-week open-label study. Simpson DM; Brown S; Tobias JK; Vanhove GF; Clin J Pain; 2014 Feb; 30(2):134-42. PubMed ID: 23446088 [TBL] [Abstract][Full Text] [Related]
19. Characteristics and outcomes of peripheral neuropathic pain patients with repeated applications of high-concentration capsaicin cutaneous patch: Results of a retrospective chart review in Germany. Kern KU; Quandel T; Theis S; Schubert T Pain Pract; 2024 Jun; 24(5):700-708. PubMed ID: 38321913 [TBL] [Abstract][Full Text] [Related]
20. Capsaicin 8% Patch Versus Oral Neuropathic Pain Medications for the Treatment of Painful Diabetic Peripheral Neuropathy: A Systematic Literature Review and Network Meta-analysis. van Nooten F; Treur M; Pantiri K; Stoker M; Charokopou M Clin Ther; 2017 Apr; 39(4):787-803.e18. PubMed ID: 28365034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]